David Sax, M.D.
NPI 1902808462 · Dermatology Physician · Sarasota, FL
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1902808462
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- ME83474 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
7,884 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,586 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,285 | $90 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 579 | $51 |
| Obtaining Data Needed to Develop the Optimal Radiation Treatment, 1 Treatment Area77280 | 528 | $257 |
| High Dose Rate Electronic Brachytherapy, External0394T | 525 | $240 |
| Biopsy of Related Skin Growth, First Growth11102 | 496 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 23 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 267 | 124 |
| Triamcinolone Acetonide | 110 | 96 |
| Doxycycline Hyclate | 99 | 49 |
| Clobetasol Propionate | 78 | 63 |
| Hydrocortisone | 57 | 50 |
| Cephalexin | 51 | 49 |
| Nystatin | 41 | 32 |
| Mupirocin | 38 | 36 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$21,702 across 27 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-08-15
- Last updated
- 2021-12-17
- Certified
- 2021-12-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.